Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Bertilsson

Showing results (191-200 of 263) with videos related to

Pageof 27
Sort By:
European Journal of Clinical Pharmacology|March 9, 2012
The dopaminergic stabilizer pridopidine is to a major extent N-depropylated by CYP2D6 in humansA Helldén, G Panagiotidis, P Johansson, et al.
Molecular Pharmacology|September 1, 1994
Genetic analysis of the Chinese cytochrome P4502D locus: characterization of variant CYP2D6 genes present in subjects with diminished capacity for debrisoquine hydroxylationI Johansson, M Oscarson, Q Y Yue, et al.
Acta Pharmacologica Et Toxicologica|January 1, 1971
Pharmacokinetics and biological effects of nortriptyline in manF Sjöqvist, B Alexanderson, M Asberg, et al.
European Journal of Clinical Pharmacology|January 1, 1993
Frequency of S-mephenytoin hydroxylation deficiency in 373 Spanish subjects compared to other Caucasian populationsJ Reviriego, L Bertilsson, J A Carrillo, et al.
Psychiatry and Clinical Neurosciences|February 1, 1997
Significance of monitoring plasma levels of amitriptyline, and its hydroxylated and desmethylated metabolites in prediction of the clinical outcome of depressive stateK Shimoda, S Yasuda, S Morita, et al.
European Journal of Clinical Pharmacology|January 3, 1977
Monoamine metabolites in cerebrospinal fluid during treatment with clonidine or alprenololL Bertilsson, K Haglund, J Ostman, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 10, 1998
1- and 3-hydroxylations, in addition to 4-hydroxylation, of debrisoquine are catalyzed by cytochrome P450 2D6 in humansB Eiermann, P O Edlund, A Tjernberg, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 15, 1993
Inherited amplification of an active gene in the cytochrome P450 CYP2D locus as a cause of ultrarapid metabolism of debrisoquineI Johansson, E Lundqvist, L Bertilsson, et al.
British Journal of Clinical Pharmacology|May 1, 1995
Interphenotype differences in disposition and effect on gastrin levels of omeprazole--suitability of omeprazole as a probe for CYP2C19M Chang, G Tybring, M L Dahl, et al.
Pharmacogenetics|December 1, 1996
CYP2C19 genotype and phenotype determined by omeprazole in a Korean populationH K Roh, M L Dahl, G Tybring, et al.
Pageof 27

Showing results (191-200 of 263) with videos related to

Sort By:
Pageof 27
European Journal of Clinical Pharmacology|March 9, 2012
The dopaminergic stabilizer pridopidine is to a major extent N-depropylated by CYP2D6 in humansA Helldén, G Panagiotidis, P Johansson, et al.
Molecular Pharmacology|September 1, 1994
Genetic analysis of the Chinese cytochrome P4502D locus: characterization of variant CYP2D6 genes present in subjects with diminished capacity for debrisoquine hydroxylationI Johansson, M Oscarson, Q Y Yue, et al.
Acta Pharmacologica Et Toxicologica|January 1, 1971
Pharmacokinetics and biological effects of nortriptyline in manF Sjöqvist, B Alexanderson, M Asberg, et al.
European Journal of Clinical Pharmacology|January 1, 1993
Frequency of S-mephenytoin hydroxylation deficiency in 373 Spanish subjects compared to other Caucasian populationsJ Reviriego, L Bertilsson, J A Carrillo, et al.
Psychiatry and Clinical Neurosciences|February 1, 1997
Significance of monitoring plasma levels of amitriptyline, and its hydroxylated and desmethylated metabolites in prediction of the clinical outcome of depressive stateK Shimoda, S Yasuda, S Morita, et al.
European Journal of Clinical Pharmacology|January 3, 1977
Monoamine metabolites in cerebrospinal fluid during treatment with clonidine or alprenololL Bertilsson, K Haglund, J Ostman, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 10, 1998
1- and 3-hydroxylations, in addition to 4-hydroxylation, of debrisoquine are catalyzed by cytochrome P450 2D6 in humansB Eiermann, P O Edlund, A Tjernberg, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 15, 1993
Inherited amplification of an active gene in the cytochrome P450 CYP2D locus as a cause of ultrarapid metabolism of debrisoquineI Johansson, E Lundqvist, L Bertilsson, et al.
British Journal of Clinical Pharmacology|May 1, 1995
Interphenotype differences in disposition and effect on gastrin levels of omeprazole--suitability of omeprazole as a probe for CYP2C19M Chang, G Tybring, M L Dahl, et al.
Pharmacogenetics|December 1, 1996
CYP2C19 genotype and phenotype determined by omeprazole in a Korean populationH K Roh, M L Dahl, G Tybring, et al.
Pageof 27